← Open Payments lookup

DOUGLAS SEGARS: Open Payments

NPI 1649553165 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$468 in 22 payments from 9 companies in 2025. Trend: 2023 $330 · 2024 $487 · 2025 $468

Food & beverage: $468
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$94
Janssen Pharmaceuticals, Inc5$93
Alkermes, Inc.3$66
Lundbeck LLC2$48
E.R. Squibb & Sons, L.L.C.2$44
ABBVIE INC.2$43
Teva Pharmaceuticals USA, Inc.2$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Luye Pharma (USA) Ltd.1$22

Products named: INGREZZA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, COBENFY, VRAYLAR, VIVITROL, ARISTADA, CAPLYTA.

Industry payments across TX — which companies pay providers there.